The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of plasma miR-371a-3p expression in patients with metastatic and early stage germ cell tumor.
 
Lucia Nappi
Honoraria - Astellas Pharma; Pfizer
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Marisa Thi
No Relationships to Disclose
 
Amy Lum
No Relationships to Disclose
 
David Huntsman
Employment - Contextual Genomics
Leadership - Contextual Genomics
Research Funding - AstraZeneca; Pfizer; Sanofi
 
Bernhard J. Eigl
Honoraria - AstraZeneca; Janssen; Merck; Pfizer; Roche Canada
Consulting or Advisory Role - AstraZeneca; Janssen; Merck; Roche Canada
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - AstraZeneca; Janssen
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
 
Christopher Martin
No Relationships to Disclose
 
Brock O Neil
No Relationships to Disclose
 
Benjamin Louis Maughan
Consulting or Advisory Role - Exelixis; Janssen Oncology; Peleton; Tempus
Travel, Accommodations, Expenses - Exelixis
 
Alan So
Honoraria - Amgen; Astellas Pharma; Janssen
Speakers' Bureau - Amgen; Astellas Pharma; Janssen
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Ferring; Janssen Oncology; MDxHealth; Merck; Roche Canada; Sanofi; Urogen pharma
Research Funding - GenomeDx; iProgen; Sitka
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Sanofi
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Alexander William Wyatt
Consulting or Advisory Role - Genzyme
Speakers' Bureau - Janssen
Research Funding - Janssen
 
Jean-Michel Lavoie
No Relationships to Disclose
 
Daniel Khalaf
Honoraria - Bayer
 
Siamak Daneshmand
No Relationships to Disclose
 
Robert James Hamilton
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
Ricardo Romao Nazario Leao
Travel, Accommodations, Expenses - Roche Pharma AG
 
Craig R. Nichols
No Relationships to Disclose
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer